Join to view full profile
2330 Shawnee Mission Pkwy Ste 210KU Cancer Center Mailstop 5003Westwood, KS 66205
Phone+1 913-588-0348
Fax+1 913-588-4085
Dr. Abdelhakim is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Kansas School of MedicineFellowship, Hematology and Medical Oncology, 2016 - 2019- University of Kansas School of MedicineResidency, Internal Medicine, 2013 - 2016
Zagazig University Faculty of MedicineClass of 2010
Certifications & Licensure
KS State Medical License 2020 - 2027
MO State Medical License 2022 - 2027
OH State Medical License 2014 - 2015
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Impact of Conditioning Intensity on Outcomes After Unrelated Donor Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis.Muhammad Kashif Amin, Moazzam Shahzad, Haritha Gandicheruvu, Nabeeha Noor, Ushna Khan
Transplantation and Cellular Therapy. 2026-08-28 - 2 citationsIntegrated proteogenomic and metabolomic profiling of acute myeloid leukemias to identify molecular subtypes and associated therapy targets.Shih-Chun A Chu, Yi Hsiao, Chenwei Wang, Jennifer E Kyle, Raghav Jain
Nature Cancer. 2026-06-01 - A phase 1b study on the safety of Wharton's jelly mesenchymal stromal cells in the treatment of acute graft-versus-host disease.William Wesson, Jianzheng Wu, Milind Phadnis, Scott Weir, Tyce Bruns
Cytotherapy. 2026-02-01
Lectures
- Older Patients with NPM1 Mutated AML Have Distinctive Genomic Mutation Landscape Associated with Enrichment in Immunosuppressive Gene Signature61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- LAG3 Inhibition Decreases AML-Induced Immunosuppression and Improves T Cell-Mediated Killing61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: